Research / Stocks / QTWO QTWO NYSE CIK 0001410384
Q2 Holdings, Inc. · Services-Prepackaged Software
COVERAGE / STANDARD
Latest filing 10-Q · Oct 28, 2026
Research state Latest filing analysis is current
Last SEC check Nov 2, 2026
Filing → research 4 min
Data basis Official SEC · no quote feed Component status Filing Evidence Research Current Official SEC filing history is available
Structured Financials Research Current Validated structured financial research is available
Filing Analysis Research Current No filing analysis job is currently running
Fundamental State Research Current Fundamental State depends on validated comparable financial metrics
RESEARCH SNAPSHOT Q2 Holdings, Inc.'s latest supported as-filed period reports revenue of $225.8M . Every value below links to its SEC accession and metric lineage.
Deterministic / evidence backed Key research observations No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Profile-correct / independently verified Company quality vector Separate current dimensions—not a universal score or investment ranking.
Evidence coverage 6 / 9 General Corporate · 2026-09-30
Growth Typical
Direction Deteriorating
Own history —
Peers 51th
Persistence EMERGING Margin Typical
Direction Stable
Own history 100th
Peers 26th
Persistence TRANSIENT Profitability Strong
Direction Improving
Own history 100th
Peers 78th
Persistence EMERGING Cash generation Strong
Direction Improving
Own history 100th
Peers 78th
Persistence EMERGING Leverage Source Unavailable
Direction Unknown
Own history —
Peers —
Persistence TRANSIENT Capital investment Context Only
Direction Stable
Own history 50th
Peers 46th
Persistence TRANSIENT R&D investment Context Only
Direction Decreasing
Own history 0th
Peers 36th
Persistence EMERGING Current configuration / point in time Fundamental state A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Capex intensity 50th Own-history percentile · N=8
Method Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.91% · OPTIONAL
Operating cash generation 100th Own-history percentile · N=8
Method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 28.65% · OPTIONAL
Revenue growth RAW Current state valid · history insufficient
Method Yoy · gp.fundamentals.revenue
Raw value 11.93% · CORE
Gross margin 100th Own-history percentile · N=8
Method Level · gp.fundamentals.gross_margin
Raw value 59.73% · CORE
Operating margin 100th Own-history percentile · N=8
Method Level · gp.fundamentals.operating_margin
Raw value 15.04% · CORE
R&D intensity 0th Own-history percentile · N=8
Method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 18.32% · OPTIONAL
SBC intensity 0th Own-history percentile · N=8
Method Level · gp.fundamentals.sbc_revenue_ratio
Deterministic multi-period research Company direction Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
As filed Sep 30, 2026 General Corporate
Capital Allocation 4 evidence-backed dimensions Capex Intensity Stable Cash Generation Improving R And D Intensity Decreasing Sbc Intensity Improving [email protected] · 9 historical states · 38% confidenceCompany Direction 7 evidence-backed dimensions Capex Intensity Stable Cash Generation Improving Margin Stable Profitability Improving R And D Intensity Decreasing [email protected] · 9 historical states · 38% confidenceFinancial Quality 4 evidence-backed dimensions Cash Generation Improving Margin Stable Profitability Improving Sbc Intensity Improving [email protected] · 9 historical states · 38% confidenceGovernance Evidence 4 evidence-backed dimensions Filing Amendments None Detected Auditor Changes None Detected Sbc Intensity Observed Insider Activity Observed [email protected] · 9 historical states · 50% confidenceInterpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Comparable evidence Peer context Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
Margin
QTWO 59.7
Peer median 73.1
Peer percentile 26th 135 valid peers · 83% coverage · -1.0 robust σ Cash Generation
QTWO 28.6
Peer median 16.5
Peer percentile 78th 146 valid peers · 90% coverage · +0.6 robust σ Profitability
QTWO 15.0
Peer median -0.2
Peer percentile 78th 149 valid peers · 92% coverage · +0.6 robust σ Sbc Intensity
QTWO 8.9
Peer median 10.7
Peer percentile 41th 143 valid peers · 88% coverage · -0.2 robust σ R And D Intensity
QTWO 18.3
Peer median 20.8
Peer percentile 36th 135 valid peers · 83% coverage · -0.2 robust σ Capex Intensity
QTWO 0.9
Peer median 1.1
Peer percentile 46th 127 valid peers · 78% coverage · -0.1 robust σ Open group breadth → Divergence is context, not positive or negative. INSIDER STATE / 90D Recent disclosed activity
Open-market purchases 0
Sales 2
Distinct buyers 0
Repeat buyer NO Conservative Form 4 classification · not a sentiment label Flagship analysis / V3 What changed? The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Current 10-Q 0001410384-26-000053 55 governed changes · top 7 shown
Operating Leverage Improvement Operating leverage improved This cluster groups 3 independently calculated changes: Revenue increased 11.9%; Operating margin moved 959 bp higher; Operating income increased 208.6%.
3 evidence-backed components Operating Leverage Improvement Operating leverage improved This cluster groups 3 independently calculated changes: Revenue increased 12.6%; Operating margin moved 831 bp higher; Operating income increased 198.2%.
3 evidence-backed components Capex Acceleration Capital spending accelerated This cluster groups 2 independently calculated changes: Capital expenditure increased 30.1%; Capex / revenue moved 10 bp higher.
2 evidence-backed components 01
HIGH IMPORTANCE Cash 100TH HISTORICAL PCTL · N=4
Cash & equivalents decreased 75.9% Cash & equivalents changed -75.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Why this ranks high
Magnitude 25
Metric Family 14
Denominator Penalty 0
Historical Unusualness 25
Persistence Or Reversal 2
Significance Percent Of Revenue 143.0427957136031670193160876
Financial Statement Significance 10
Lowest Level true
Sample Count 4
Highest Level false
As-filed financials Financial trajectory Each point keeps the date investors could first observe it and its accession.
As filed Current normalized · later
Capex / revenue 0.91% +18.0% ↑ Capital expenditure $2.1M +21.2% ↑ Cash & equivalents $116.3M +16.4% ↑ Deposits $0 -100.0% ↓ Free-cash-flow proxy $62.6M +6.2% ↑ Gross margin 59.73% +0.8% ↑ Net income $33.2M +11.3% ↑ Operating cash flow $64.7M +6.6% ↑
ACTIVE TRACE Revenue QTWO · as filed with the SEC · reported-date aware
Capex / revenue Q3 / 2026-09-30 0.91% +18.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Capital expenditure Q3 / 2026-09-30 $2.1M +21.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Cash & equivalents Q3 / 2026-09-30 $116.3M +16.4% sequential point Trace ↗ Evidence inspector
Loading lineage… × Deposits FY / 2016-12-31 $0 -100.0% sequential point Trace ↗ Evidence inspector
Loading lineage… × Free-cash-flow proxy Q3 / 2026-09-30 $62.6M +6.2% sequential point Trace ↗ Evidence inspector
Loading lineage… × Gross margin Q3 / 2026-09-30 59.73% +0.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Net income Q3 / 2026-09-30 $33.2M +11.3% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating cash flow Q3 / 2026-09-30 $64.7M +6.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Operating margin Q3 / 2026-09-30 15.04% +12.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Research & development Q3 / 2026-09-30 $41.4M +0.6% sequential point Trace ↗ Evidence inspector
Loading lineage… × Revenue Q3 / 2026-09-30 $225.8M +2.7% sequential point Trace ↗ Evidence inspector
Loading lineage… × Stock-based compensation Q3 / 2026-09-30 $20.0M -2.8% sequential point Trace ↗ Evidence inspector
Loading lineage… × Primary evidence Filing timeline Direct SEC links, filing dates, report periods, and amendment flags.
10-Q Oct 28, 2026 Period Sep 30, 2026 0001410384-26-000065SEC ↗ 8-K Oct 28, 2026 Period Oct 28, 2026 0001410384-26-000063SEC ↗ 8-K Oct 28, 2026 Period Oct 28, 2026 0001410384-26-000062SEC ↗ 4 Sep 11, 2026 Period Sep 11, 2026 0001938943-26-000010SEC ↗ 4 Aug 14, 2026 Period Aug 13, 2026 0001806954-26-000009SEC ↗ 4 Aug 12, 2026 Period Aug 10, 2026 0001719016-26-000008SEC ↗ 10-Q Jul 29, 2026 Period Jun 30, 2026 0001410384-26-000053SEC ↗ Form 4 Insider activity Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
“Insider purchase” rule Code P · non-derivative · acquired · direct ownership · positive price and shares · not amended
Inspectable by design
Every displayed number has a lineage. GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗